drugset / Trial / NCT04934696
A Study to Characterize the Drug Levels of an Oral Contraceptive With and Without BMS-986166 in Healthy Female Participants of Childbearing Potential
NaSequentialOpen-labelBasic science
Summary
The purpose of this study is to investigate the potential for a drug-drug interaction (DDI) when BMS-986166 and hormonal oral contraceptives are co-administered.
Timeline
- Start
- 2021-08-03
- Primary completion
- 2022-01-25
- Completion
- 2022-01-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BMS-986166 | Small molecule | — | — |
| Subject | Norethindrone | Unknown | — | — |
| Subject | ethinyl estradiol | Small molecule | — | — |
Indications
No indication recorded.